Healthcare provider profile · identity verified

Joseph C Linscott, DO

Family Practice · MARYSVILLE, OH · NPI 1811993801

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	643	182
Amlodipine Besylate	Amlodipine Besylate	501	152
Lisinopril	Lisinopril	490	137
Levothyroxine Sodium	Levothyroxine Sodium	432	114
Metformin Hcl	Metformin Hcl	416	93
Metoprolol Succinate	Metoprolol Succinate	386	104
Losartan Potassium	Losartan Potassium	382	116
Gabapentin	Gabapentin	314	92
Prednisone	Prednisone	291	142
Omeprazole	Omeprazole	278	87
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	260	78
Potassium Chloride	Potassium Chloride	257	62
Sertraline Hcl	Sertraline Hcl	244	71
Furosemide	Furosemide	218	74
Metoprolol Tartrate	Metoprolol Tartrate	200	59
Tramadol Hcl	Tramadol Hcl	195	63
Tamsulosin Hcl	Tamsulosin Hcl	194	68
Glipizide Er	Glipizide	185	60
Albuterol Sulfate Hfa	Albuterol Sulfate	178	92
Allopurinol	Allopurinol	176	53
Doxycycline Hyclate	Doxycycline Hyclate	170	126
Rosuvastatin Calcium	Rosuvastatin Calcium	170	53
Montelukast Sodium	Montelukast Sodium	167	52
Pantoprazole Sodium	Pantoprazole Sodium	156	50
Januvia	Sitagliptin Phosphate	152	39
Trazodone Hcl	Trazodone Hcl	151	40
Buspirone Hcl	Buspirone Hcl	147	31
Eliquis	Apixaban	147	42
Carvedilol	Carvedilol	143	47
Alendronate Sodium	Alendronate Sodium	139	50
Warfarin Sodium	Warfarin Sodium	139	28
Simvastatin	Simvastatin	138	42
Ropinirole Hcl	Ropinirole Hcl	134	38
Hydrochlorothiazide	Hydrochlorothiazide	117	37
Fluticasone Propionate	Fluticasone Propionate	116	66
Alprazolam	Alprazolam	110	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	108	27
Meloxicam	Meloxicam	108	37
Baclofen	Baclofen	106	40
Duloxetine Hcl	Duloxetine Hcl	106	28
Fenofibrate	Fenofibrate Nanocrystallized	105	32
Atenolol	Atenolol	100	29
Finasteride	Finasteride	92	33
Clopidogrel	Clopidogrel Bisulfate	90	23
Hydroxyzine Pamoate	Hydroxyzine Pamoate	90	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	87	65
Cephalexin	Cephalexin	86	54
Ozempic	Semaglutide	81	21
Esomeprazole Magnesium	Esomeprazole Magnesium	78	22
Pioglitazone Hcl	Pioglitazone Hcl	75	24
Mupirocin	Mupirocin	71	49
Torsemide	Torsemide	71	25
Oxybutynin Chloride Er	Oxybutynin Chloride	70	24
Pravastatin Sodium	Pravastatin Sodium	70	18
Hydroxyzine Hcl	Hydroxyzine Hcl	66	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	63	19
Zolpidem Tartrate	Zolpidem Tartrate	62	suppressed
Donepezil Hcl	Donepezil Hcl	61	23
Glipizide	Glipizide	61	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Propranolol Hcl Er	Propranolol Hcl	59	suppressed
Spironolactone	Spironolactone	59	24
Meclizine Hcl	Meclizine Hcl	56	21
Ondansetron Hcl	Ondansetron Hcl	56	30
Azithromycin	Azithromycin	54	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	53	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	53	38
Amitriptyline Hcl	Amitriptyline Hcl	52	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	15
Hydralazine Hcl	Hydralazine Hcl	48	16
Sucralfate	Sucralfate	48	21
Citalopram Hbr	Citalopram Hydrobromide	46	14
Venlafaxine Hcl Er	Venlafaxine Hcl	46	suppressed
Ondansetron Odt	Ondansetron	44	19
Fluconazole	Fluconazole	43	16
Mometasone Furoate	Mometasone Furoate	42	35
Chlorthalidone	Chlorthalidone	41	18
Oxycodone Hcl	Oxycodone Hcl	39	11
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Levetiracetam	Levetiracetam	35	suppressed
Synthroid	Levothyroxine Sodium	35	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	35	15
Tizanidine Hcl	Tizanidine Hcl	34	11
Ezetimibe	Ezetimibe	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	12
Nifedipine Er	Nifedipine	30	suppressed
Clonazepam	Clonazepam	28	suppressed
Diazepam	Diazepam	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Valproic Acid	Valproic Acid	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Estradiol	Estradiol	26	suppressed
Famotidine	Famotidine	26	11
Lorazepam	Lorazepam	26	suppressed
Memantine Hcl	Memantine Hcl	26	12
Mirtazapine	Mirtazapine	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Levofloxacin	Levofloxacin	24	20
Novolog Flexpen	Insulin Aspart	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Temazepam	Temazepam	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Amoxicillin	Amoxicillin	22	16
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Bupropion Xl	Bupropion Hcl	22	11
Clonidine Hcl	Clonidine Hcl	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Nitroglycerin	Nitroglycerin	21	19
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Nateglinide	Nateglinide	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Methylprednisolone	Methylprednisolone	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Nystatin	Nystatin	16	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	15	15
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Famciclovir	Famciclovir	14	11
Memantine Hcl Er	Memantine Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Colchicine	Colchicine	13	11
Divalproex Sodium	Divalproex Sodium	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	12	11
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Naproxen	Naproxen	11	suppressed
Ramipril	Ramipril	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error